
Pharmaceutical Technology's In the Lab eNewsletter
Advanced HDX-MS and native MS techniques can be used to improve the identification of potentially successful biologic drugs and take the risk out of CMC and clinical designs.
Jennifer S. Chadwick, PhD, is director of biologic development at BioAnalytix.

Pharmaceutical Technology's In the Lab eNewsletter
Advanced HDX-MS and native MS techniques can be used to improve the identification of potentially successful biologic drugs and take the risk out of CMC and clinical designs.

Using advanced HDX-MS and native MS techniques can improve the identification of potentially successful biologic drugs and de-risk CMC and clinical designs.